|Articles|May 1, 2001

Cost and Utilization Analysis for Allergic Rhinitis Treatments
Volume 7
Issue 4 Suppl

Report: A Descriptive Analysis of the Use and Cost of New-Generation Antihistamines in the Treatment of Allergic Rhinitis: A Retrospective Database Analysis

Author(s)Jeff Lee, PharmD, Gordon Cummins, MS, Lynn Okamoto, PharmD

Download PDF: Report: A Descriptive Analysis of the Use and Cost of New-Generation Antihistamines in the Treatment of Allergic Rhinitis: A Retrospective Database Analysis

Articles in this issue

about 25 years ago

Article

Participating Faculty

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe

Related Content

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

ByHeather L. Taylor, MPH, LDH,Ann M. Holmes, PhD,Nir Menachemi, PhD, MPH,Justin Blackburn, PhD

July 10th 2026

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

ByChristopher Scannell, MD, PhD,John A. Romley, PhD,Rebecca Myerson, PhD,Dana Goldman, PhD,Dima Mazen Qato, PharmD, PhD, MPH

July 9th 2026

Upper Payment Limit Implementation Risks for Patients, Pharmacies, and Providers

ByJulie A. Patterson, PharmD, PhD,Roswell A. Cole, PharmD, MPH,Jonathan D. Campbell, PhD, MS,John Michael O’Brien, PharmD, MPH

July 9th 2026

The New Oncology Blueprint: Integrating Clinical Intelligence for Sustainable Value

ByVivian T. E. Tar, PharmD, MBA

July 8th 2026

Readability of Hospital Patient Financial Policy Documents

BySamantha Randall, BA,Sumedha Raghu, MS,Ella Cho,Nina Linh Nguyen, MHA,Erin Trish, PhD,Erin L. Duffy, PhD, MPH

July 7th 2026

Report: A Descriptive Analysis of the Use and Cost of New-Generation Antihistamines in the Treatment of Allergic Rhinitis: A Retrospective Database Analysis

Articles in this issue

Related Content

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

Upper Payment Limit Implementation Risks for Patients, Pharmacies, and Providers

The New Oncology Blueprint: Integrating Clinical Intelligence for Sustainable Value

Readability of Hospital Patient Financial Policy Documents

Trending on AJMC

New Survey Highlights Quality-of-Life Benefits of Dry Eye Disease Treatment

Team-Based Telehealth Model Matches In-Person Care for Atopic Dermatitis

JAK Inhibitors Reshaped Alopecia Areata Care, but Long-Term Data Gaps Remain

Biologics Appear Renal-Safe in Psoriasis, IL-17 Agents Show Kidney Promise

Comprehensive Smoke-Free Laws Linked to Sustained Drop in CVD Mortality

Access, Affordability, & Accountability: A New Era in Oncology Reimbursement

Report: A Descriptive Analysis of the Use and Cost of New-Generation Antihistamines in the Treatment of Allergic Rhinitis: A Retrospective Database Analysis

Articles in this issue

Related Content

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

Upper Payment Limit Implementation Risks for Patients, Pharmacies, and Providers

The New Oncology Blueprint: Integrating Clinical Intelligence for Sustainable Value

Readability of Hospital Patient Financial Policy Documents

Trending on AJMC

New Survey Highlights Quality-of-Life Benefits of Dry Eye Disease Treatment

Team-Based Telehealth Model Matches In-Person Care for Atopic Dermatitis

JAK Inhibitors Reshaped Alopecia Areata Care, but Long-Term Data Gaps Remain

Biologics Appear Renal-Safe in Psoriasis, IL-17 Agents Show Kidney Promise

Comprehensive Smoke-Free Laws Linked to Sustained Drop in CVD Mortality